ONPH (Oncology Pharma) Notes Receivable: $0.00 Mil (As of Dec. 2004)


What is Oncology Pharma Notes Receivable?

Oncology Pharma ONPH -21.43% Notes Receivable is $0.00 Mil as of Dec. 2004.

Oncology Pharma's Notes Receivable for the quarter that ended in Dec. 2004 was $0.00 Mil.

Oncology Pharma Notes Receivable Related Terms

Oncology Pharma Notes Receivable Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Notes Receivable Chart

Oncology Pharma Annual Data
Trend Jun96 Jun97 Jun98 Mar00 Mar01 Mar02 Mar03
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Oncology Pharma Quarterly Data
Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oncology Pharma Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Oncology Pharma (ONPH) has a Notes Receivable of $0.00 Mil as of Dec. 2004. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Oncology Pharma and its competitors.
Is Oncology Pharma's Notes Receivable too high?
Oncology Pharma's current Notes Receivable is $0.00 Mil.
How does Oncology Pharma's Notes Receivable compare to TAUG and IMUN?
Oncology Pharma's Notes Receivable of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Diversified Financial Services company?
A good Notes Receivable depends on the Diversified Financial Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Oncology Pharma and its competitors. Oncology Pharma's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Notes Receivable is $0.00 Mil as of Dec. 2004. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc is a shell company and currently has no operations.